Ironwood Pharmaceuticals IRWD Increase (Decrease) in Other Operating Assets
Increase (Decrease) in Other Operating Assets at other companies
Other financials
Where this comes from
Reported directly by Ironwood Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherOperatingAssets.
The official record: Ironwood Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ironwood Pharmaceuticals's increase (decrease) in other operating assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ironwood Pharmaceuticals's increase (decrease) in other operating assets?
- Ironwood Pharmaceuticals (IRWD) reported increase (decrease) in other operating assets of -$121K in Q1 2026.
- How has Ironwood Pharmaceuticals's increase (decrease) in other operating assets changed year-over-year?
- Ironwood Pharmaceuticals's increase (decrease) in other operating assets increased by 14.2% year-over-year, from -$141K to -$121K.
- What is the long-term trend for Ironwood Pharmaceuticals's increase (decrease) in other operating assets?
- Over 2 years (2021 to 2025), Ironwood Pharmaceuticals's increase (decrease) in other operating assets has grown at a 180.0% compound annual growth rate (CAGR), from $57K to -$447K.
- What does increase (decrease) in other operating assets mean?
- This captures the net change in miscellaneous assets that are not classified as loans, securities, or property, plant, and equipment. It often includes items like accrued interest receivables, prepaid expenses, and other short-term operational assets.